Fisher & Paykel boss Lewis Gradon gets hefty pay boost after hitting targets

Fisher & Paykel boss Lewis Gradon gets hefty pay boost after hitting targets
Fisher & Paykel Healthcare and its managing director Lewis Gradon hit targets for operating revenue, profit and cashflow. (Image: NZME)
Rebecca Stevenson
New Zealand Exchange-listed medical device manufacturer Fisher & Paykel Healthcare says the feedback from US customers on its new solo mask for obstructive sleep apnea has been tremendous. Fisher & Paykel reported its full-year result to March 31 on Wednesday, reporting underlying net profit after tax of $264.4 million after stripping out one-off items including a $98m revaluation of land it purchased at Karaka. Free cashflow rose to $73.8m compared to $12.5m in the previous financial year, while operating revenue wa...

More Markets

Banks revise economic outlooks for Q2 GDP contraction
Finance

Banks revise economic outlooks for Q2 GDP contraction

Economists now see NZ's GDP contracting in Q2, but doubt a technical recession in Q3.

NZ stocks end flat as US Fed decision looms
Markets Market Close

NZ stocks end flat as US Fed decision looms

Market finishes slightly down as telco company Spark loses more ground.

Jamie Gray 12 Sep 2025
Locate Technologies plans to quit ASX for NZX
Markets

Locate Technologies plans to quit ASX for NZX

Bitcoin-favouring Locate Technologies eyes move to NZX's main board.

Staff reporters 12 Sep 2025